ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693169 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693169; 2) Community: the network communities that were significantly associated with the response to NSC 693169; 3) Molecule: the relationships between components within communities and NSC 693169; 4) MDR: the compounds that were significantly associated with the NSC 693169.

NSC Compound Enrichment Correlation
NSC 95779 Null 0.0219468083770723 0.046908543
NSC 123528 Alanine, 3-[(p-methoxy-.alpha.,.alpha.-diphenylbenzyl)thio]-, hydrate [4:1] 0.022188614181866 0.19071772
NSC 154948 M-AMSA 0.022188614181866 0.50510123
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.022188614181866 0.41426565
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.022188614181866 0.35033474
NSC 300289 Pinafide 0.022188614181866 0.45109335
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.022188614181866 0.048563989
NSC 39215 Null 0.022188614181866 0.14951404
NSC 47468 Null 0.022188614181866 0.33347024
NSC 606499 Camptothecin Derivative 0.022188614181866 0.52483742
Total:58  Current:28    [First] [Prev] [Next] [Last]